To understand the distinct lectin binding, specifically Gal-1, to SLE T cells, we found that the terminal sialylation increased in the autoimmune cells, and accordingly, neuraminidase treatment resulted in a remarkable increase in Gal-1 binding. The gene discussed is LGALS1; the disease is systemic lupus erythematosus.